Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkdcdxnph mutation
(0 available);
any
Prkdc mutation
(408 available)
|
|
|
homeostasis/metabolism
renal/urinary system
|
• onset of proteinuria about 5 days after DOX injection
|
|
• severe susceptibility to doxorubicin (DOX) nephropathy
|
|
• progress to significant glomerulosclerosis within 14 days of DOX injections
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkdcdxnph mutation
(0 available);
any
Prkdc mutation
(408 available)
|
|
|
cellular
|
• increased sensitivity to gamma irradition of mammary cells
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkdcdxnph mutation
(0 available);
any
Prkdc mutation
(408 available)
|
|
|
homeostasis/metabolism
renal/urinary system
|
• onset of proteinuria about 5 days after DOX injection
|
|
• severe susceptibility to doxorubicin (DOX) nephropathy
|
|
• progress to significant glomerulosclerosis within 14 days of DOX injections
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkdcdxnph mutation
(0 available);
any
Prkdc mutation
(408 available)
|
|
|
homeostasis/metabolism
renal/urinary system
|
• susceptibility to doxorubicin-induced proteinuria
|
|
• susceptibility to doxorubicin-induced glomerulosclerosis
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation
(12 available);
any
Apc mutation
(154 available)
Pla2g2aMom1-r mutation
(0 available);
any
Pla2g2a mutation
(7 available)
Prkdcdxnph mutation
(0 available);
any
Prkdc mutation
(408 available)
|
|
|
neoplasm
|
• mice show 2-3 fold increase in adenoma incidence in the small intestine after X-irradiation
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dxmod mutation
(0 available);
any
Dxmod mutation
(0 available)
Prkdcdxnph mutation
(0 available);
any
Prkdc mutation
(408 available)
|
|
|
renal/urinary system
|
• susceptibility to doxorubicin-induced glomerulosclerosis
|
|
• susceptibility to doxorubicin-induced microcystic tubular dilations
|